As of 8:10 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
Robert C. Moellering Jr., M.D. | |
| Age | Total Calculated Compensation | This person is connected to 164 board members in 16 different organizations across 17 different industries.
See Board Relationships |
| -- | --
|
Background*
Dr. Robert C. Moellering, Jr., M.D. serves as a Clinical Advisor of Enanta Pharmaceuticals, Inc. Dr. Moellering serves as an Editor-in-Chief of Antimicrobial Agents and Chemotherapy and serves as Editor of both Infectious Disease Clinics of North America and European Journal of Clinical Microbiology and Infectious Diseases. He served as President and Chief Executive Officer of Harvard Medical Faculty Physicians of Beth Israel Deaconess Medical Center, the faculty multispecialty ... practice group at BIDMC. He served as Physician-in-Chief of Beth Israel Deaconess Medical Center (BIDMC), Boston until 2005. Dr. Moellering has been Chairman and Member of the Scientific Advisory Board of Pyro Pharmaceuticals, Inc. since November 2009. He has been the Chairman of Clinical Advisory Board at T2 Biosystems, Inc. since May 2011. He has been the Chairman of the Clinical Advisory Board at Rib-X Pharmaceuticals, Inc. since September 2008. He has been a Director of NanoBio Corporation since September 2006. He serves as Member of Scientific Advisory Board at Semprus BioSciences Corp. He serves as a Member of Scientific Advisory Board at Calixa Therapeutics, Inc., BioRelix, Inc., Exponential Biotherapies, Inc., Cerexa, Inc. Microbiotix, Inc. and Novexel SA. He serves as a Member of Clinical Advisory Board at Tetraphase Pharmaceuticals, Inc., and Trius Therapeutics, Inc. He serves as a Member of the Supervisory Board at Nabriva Therapeutics AG. He served as a Member of Scientific Advisory Board of MiddleBrook Pharmaceuticals, Inc. (alternate name Advancis Pharmaceutical Corp.) since November 24, 2003. He serves as Member of Scientific Advisory Board at Affinium Pharmaceuticals, Inc. and Fedora Pharmaceuticals Inc. He served as a Member of Clinical Advisory Board of Quorex Pharmaceuticals, Inc., and Rx3 Pharmaceuticals, Inc. He served as a Member of Scientific Advisory Board of Rib-x Pharmaceuticals Inc. until September 2008. He served as a Member of Scientific Advisory Board of Targanta Therapeutics Corp. He serves as Herman Ludwig Blumgart Professor of Medicine of Harvard Medical School. Dr. Moellering is one of the best known and most respected physicians in the United States. He is Physician-in-Chief of Harvard's main teaching hospital, Beth Israel-Deaconess Medical Center. He is a world-renowned leader in Infectious Diseases, and has extensive experience in biomedical entrepreneurship. He is Editor or Editor-in-Chief of a number of prestigious journals, such as the New England Journal of Medicine, Antimicrobial Agents & Chemotherapy, and Annals of Internal Medicine. He was Chairman of the HIV Therapeutics Trials Data and Safety Monitoring Board of the National Institute of Allergy and Infectious Disease, National Institutes of Health. He was on the Advisory Panel on Antimicrobial Resistance of the Office of Technology Assessment (OTA), U.S. Congress. He was on the American Society of Microbiology Task Force on Antimicrobial Resistance. In 1977 there was a feature article about him in The Lancet. He was listed in The International Who's Who in Medicine. Dr. Moellering's principal research interests are: Mechanisms of Antimicrobial Interactions, Mechanisms of Resistance to Antimicrobial Agents , Mechanisms of Action of Antimicrobial Agents, Pharmacokinetics of Antimicrobial Agents , In Vitro Evaluation of New Antimicrobial Agents and In Vivo Models of Infection and Chemotherapy. He served as the Shields Warren-Mallinckrodt Professor of Medical Research of Harvard Medical School from 1981 to 1999. Trained as an infectious diseases specialist, Dr. Moellering has been actively involved in laboratory research for 35 years carrying out numerous studies of the mechanism of action and mechanisms of resistance to antimicrobial agents. He serves as Chairman of one of the major academic departments of medicine at Harvard Medical School. He served as Chairman of the Department of Medicine at Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts from 1981 to 1996. He served as Physician-in-Chief at the New England Deaconess Hospital from 1981 to 1996. He served as President of Infectious Diseases Society of America from 1990 to 1991. A recognized expert in his field, he is a Member of several professional organizations, including the Infectious Disease Society of America and the American Academy of Microbiology. As reported in over 400 publications in scientific journals, his work includes numerous studies of the mechanism of action and mechanisms of resistance to antimicrobial agents. He has defined some of the important mechanisms of interaction of antimicrobial agents, particularly against the enterococcus which has been a particular investigative interest for many years. He is the recipient of several prestigious awards, including the Garrod Medal from the British Society for Antimicrobial Chemotherapy, the Feldman Award from the Infectious Diseases Society of America and the Hoechst-Roussel Award from the American Academy of Microbiology. Dr. Moellering is the 2006 recipient of the Maxwell Finland Award for Scientific Achievement from the National Foundation for Infectious Diseases. He is a Fellow of the Infectious Diseases Society of America, Master of the American College of Physicians and has been elected to membership in the American Society for Clinical Investigation and the Association of American Physicians. Dr. Moellering was a Research Fellow in Infectious Disease, Department of Medicine, Massachusetts General Hospital and was a Clinical Fellow in Infectious Disease, Department of Medicine, Massachusetts General Hospital. He is also an Honorary Fellow of the Royal College of Physicians. Dr. Moellering holds an Honorary Doctor of science degree from Valparaiso University. He holds an M.D. degree cum laude from Harvard Medical School and completed his internship and residency at Massachusetts General Hospital. He holds Masters degree of the American College of Physicians. He holds B.A. in Zoology from Valparaiso University.
Corporate Headquarters*
500 Arsenal Street
Watertown, Massachusetts 02472
United States
Phone: 617-607-0800
Fax: 617-607-0530
Board Members Memberships*
2006-Present Director
Education*
MD Harvard Medical School Honorary Doctorate Valparaiso University BA Valparaiso University Master's Degree American College of Physicians
Other Affiliations*
|
Annual Compensation*
There is no Annual Compensation data available.
Stock Options*
There is no Stock Options data available.
Total Compensation*
There is no Total Compensation data available.
|
*Data is at least as current as the most recent Definitive Proxy.
